Cellebrite DI Ltd.
CLBT
$19.45
-$0.11-0.56%
NASDAQ
| 12/31/2024 | 06/30/2024 | 12/31/2023 | 09/30/2023 | ||
|---|---|---|---|---|---|
| Net Income | 19.27M | -23.81M | -14.65M | 6.50M | |
| Total Depreciation and Amortization | 2.73M | 2.58M | 2.62M | 2.38M | |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | |
| Total Other Non-Cash Items | 3.75M | 40.80M | 34.46M | 14.55M | |
| Change in Net Operating Assets | 40.22M | -5.05M | 21.40M | 5.75M | |
| Cash from Operations | 65.97M | 14.51M | 43.83M | 29.18M | |
| Capital Expenditure | -3.18M | -2.07M | -2.26M | -1.08M | |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | |
| Cash Acquisitions | 0.00 | -- | -- | -- | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | -12.77M | -31.19M | 5.42M | -9.81M | |
| Cash from Investing | -15.95M | -33.26M | 3.16M | -10.90M | |
| Total Debt Issued | -- | -- | -- | -- | |
| Total Debt Repaid | -- | -- | -- | -- | |
| Issuance of Common Stock | 6.73M | 3.32M | 4.53M | 8.82M | |
| Repurchase of Common Stock | -- | -- | -- | -- | |
| Issuance of Preferred Stock | -- | -- | -- | -- | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -- | -- | -- | -- | |
| Other Financing Activities | 0.00 | -- | -- | -- | |
| Cash from Financing | 6.73M | 3.32M | 4.53M | 8.82M | |
| Foreign Exchange rate Adjustments | -1.44M | -49.00K | 932.00K | -535.00K | |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | |
| Net Change in Cash | 55.31M | -15.48M | 52.45M | 26.56M | |